Companies → CVS Health Corporation
Save to list
Remove

CVS Health Corporation

United States, Rhode Island, Woonsocket
Description
CVS Health Corp. is a leading pharmacy benefits manager with approximately 108 million plan members as well as the nation's largest drugstore chain. It runs approximately 9,000 retail locations. more than 1,000 walk-in medical clinics, and more than 200 primary care medical clinics. The company maintains a national network of approximately 66,000 retail pharmacies, consisting of approximately 38,000 chain pharmacies (which include CVS pharmacy locations) and approximately 28,000 independent pharmacies, in the US, including Puerto Rico, the District of Columbia, Guam, and the US Virgin Islands and runs a panel of healthcare professionals, Caremark National Pharmacy and Therapeutics Committee. CVS Health also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services.
Address:

1 CVS Dr Woonsocket

RI

02895-6146 United States

Revenue
Recent news:

Best Healthcare Stocks to Buy After the Market Pullback

They have the means to recover from recent setbacks.

Source: Motley Fool Mar 20, 2026

Alphabet Taps Health100 To Extend Gemini Deeper Into Consumer Healthcare

Google Cloud and CVS Health announced Health100, an AI powered health engagement platform, scheduled to launch in 2026. The platform is planned to use Gemini AI models, interoperability tools, and multimodal AI to support real time health engagement. Health100 is expected to cover pharmacy, insurance, and digital health, including integration of biometric data from wearables. The collaboration marks an expansion of Alphabet’s NasdaqGS:GOOGL efforts in connected digital health and open...

Source: Simply Wall St. Mar 19, 2026

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Source: Zacks Mar 19, 2026

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

In the most recent trading session, CVS Health (CVS) closed at $74.81, indicating a -1.36% shift from the previous trading day.

Source: Zacks Mar 17, 2026

Street Calls of the Week

Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week.

Source: Investing.com Mar 16, 2026

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Source: Motley Fool Mar 15, 2026

NYSE - Delayed Quote - USD
CVS
71.48 -0.38 (-0.53%)
At close March 20 20:00 UTC
71.96 +0.48 (+0.67%)
After hours: March 20 23:35 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/20/2026
Market Cap: 90.94 B
Enterprise Value: 160.29 B
Trailing P/E: 51.42
Forward P/E: 9.98
PEG Ratio (5yr expected): 0.21
Price/Sales (ttm): 0.23
Price/Book (mrq): 1.21
Enterprise Value/Revenue: 0.40
Enterprise Value/EBITDA: 16.25
Financial Highlights
Profitability and Income Statement
Profit Margin: 0.44%
Return on Assets (ttm): 2.47%
Return on Equity (ttm): 2.29%
Revenue (ttm): 399.83 B
Net Income Avi to Common (ttm): 1.77 B
Diluted EPS (ttm): 1.39
Balance Sheet and Cash Flow
Total Cash (mrq): 10.60 B
Total Debt/Equity (mrq): 106.06%
Levered Free Cash Flow (ttm): 5.93 B
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.